News

Scientists create antibody ‘cocktail’ to fight deadly Lassa virus

Jared Sagoff
By Jared Sagoff
April 8, 2023

Antibodies are a crucial ingredient in preventing infection for a wide variety of viruses. Scientists are frequently looking for new antibodies that could help fight viral infections. One deadly virus, the Lassa virus, infects hundreds of thousands of people annually, predominantly in Africa, causing its namesake: Lassa fever. There is as yet no approved vaccine or therapeutic against Lassa fever.

Now, however, scientists have identified three major monoclonal antibodies — artificial proteins that act like antibodies in the immune system — that can be used to potentially form the basis of a new vaccine that could save tens of thousands of lives a year.

A transmission electron micrograph of a number of Lassa virus virions adjacent to cell debris. The virus causes Lassa fever.
A transmission electron micrograph of a number of Lassa virus virions adjacent to cell debris. The virus causes Lassa fever.

The research team was led by Erica Ollmann Saphire, the president and CEO of the La Jolla Institute for Immunology, an organization dedicated to understanding and combating infectious diseases. Researchers from LJI used the bright X-ray beams produced by the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science user facility at DOE’s Argonne National Laboratory, to characterize three antibodies that target the Lassa virus’s protein structure. The antibodies were isolated from survivors of the disease.

The result is a culmination of a 17-year project to look at the action of the Lassa virus and try to create a suite of biological molecules that could inhibit the virus’s ability to infect human cells.

“These antibodies are protective, but people weren’t sure why they were protective,” said Haoyang Li, a researcher at LJI and the first author on a paper based on the study. ​“The work done at the APS allowed us to see what was happening on a molecular level.”

“People may be familiar with monoclonal antibodies as a treatment for viruses such as the virus that causes COVID-19, but these kinds of antibodies can have positive effects on other viruses as well, like Lassa,” added Argonne physicist Naga Venugopalan.

According to Li, viruses such as Lassa are enveloped by a substance called glycoprotein. This glycoprotein is in turn equipped with a ​“glycan shield” made of carbohydrate molecules that typically both protects the virus from antibody attack and enables it to infect cells.

“Normally, antibodies cannot find a way to get through the glycan shield to get access to the protein to destroy the virus, but in our research we found that some of the antibodies could actually exploit the shield itself to reach the glycoprotein and neutralize the virus,” Li said.

The researchers strove to identify the virus’s weak spots, and they found that the most effective approach involved the use of a ​“cocktail” of the three antibodies to neutralize the virus. The antibody cocktail has been tested in nonhuman primates but is still awaiting federal approval for further study in humans. In the meantime, the researchers were interested in more fully understanding how the antibodies worked.

To do so, they used a combination of cryo-electron microscopy (cryo-EM) technology provided by LJI, and X-ray crystallography with X-rays provided by the APS. Partial structures of the three different antibodies and interaction of the glycoprotein complex with one of the antibodies were determined by X-ray crystallography. This information was used as an initial model when helping to fill out the atomic maps produced by the cryo-EM.

“X-ray crystallography provides us with a way to see the finer details of interactions between two proteins, namely, the side chain interactions,” Venugopalan said. ​“Information obtained from X-ray crystallography provides better clarity when fitting cryo-electron density maps.”

The ultimate goal would be to develop a vaccine that could drive the body into producing these antibodies naturally. ​“Because each of these antibodies in the cocktail can simultaneously bind to the glycoprotein, it creates the potential for a more effective treatment against Lassa virus than we have had to date.” Venugopalan said.

This article was first published by Argonne National Laboratory. Read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Jared Sagoff
Jared Sagoff

Jared Sagoff is a coordinating writer/editor and public information officer at the U.S. Department of Energy’s Argonne National Laboratory who covers physical science research, including physics, chemistry, materials science and nanotechnology.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Cracking the recipe for perfect plant-based eggs
News

Cracking the recipe for perfect plant-based eggs

Dec. 8, 2024

It involves finding just the right proteins. With new ingredients and processes, the next generation of substitutes will be not just more egg-like, but potentially more nutritious.

MSU researchers leverage cryo-EM for decades-in-the-making breakthrough
News

MSU researchers leverage cryo-EM for decades-in-the-making breakthrough

Dec. 7, 2024

Lee Kroos and Ben Orlando have reported the first high-resolution experimentally determined structures of the intramembrane protease SpolVFB.

From the Journals: MCP
Journal News

From the Journals: MCP

Dec. 6, 2024

Rapid and precise SARS-CoV-2 detection using mass spec. Mapping brain changes from drug addiction. Decoding plant osmotic stress response. Read about recent MCP papers on these topics.

What seems dead may not be dead
Award

What seems dead may not be dead

Dec. 4, 2024

Vincent Tagliabracci will receive the Earl and Thressa Stadtman Distinguished Scientist Award at the ASBMB Annual Meeting, April 12–15 in Chicago.

'You can't afford to be 15 years behind the parasite'
Award

'You can't afford to be 15 years behind the parasite'

Dec. 3, 2024

David Fidock will receive the Alice and C.C. Wang Award in Molecular Parasitology at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Elucidating how chemotherapy induces neurotoxicity
Award

Elucidating how chemotherapy induces neurotoxicity

Dec. 2, 2024

Andre Nussenzweig will receive the Bert and Natalie Vallee Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.